Comorbidities in chronic obstructive pulmonary disease from assessment to treatment.

Comorbidities in chronic obstructive pulmonary disease from assessment to treatment. - PDF Download Free
440KB Sizes 2 Downloads 7 Views

Recommend Documents


Chronic obstructive pulmonary disease and comorbidities.
Results of epidemiological studies have shown that chronic obstructive pulmonary disease (COPD) is frequently associated with comorbidities, the most serious and prevalent being cardiovascular disease, lung cancer, osteoporosis, muscle weakness, and

Underrecognized comorbidities of chronic obstructive pulmonary disease.
COPD is associated with different comorbid diseases, and their frequency increases with age. Comorbidities severely impact costs of health care, intensity of symptoms, quality of life and, most importantly, may contribute to life span shortening. Som

Comorbidities and systemic effects of chronic obstructive pulmonary disease.
Although primarily a lung disease, chronic obstructive pulmonary disease (COPD) is now recognized to have extrapulmonary effects on distal organs, the so-called systemic effects and comorbidities of COPD. Skeletal muscle dysfunction, nutritional abno

From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration.
Deep mining of healthcare data has provided maps of comorbidity relationships between diseases. In parallel, integrative multi-omics investigations have generated high-resolution molecular maps of putative relevance for understanding disease initiati

Assessment of pulmonary rehabilitation efficacy in chronic obstructive pulmonary disease patients using the chronic obstructive pulmonary disease assessment test.
We evaluated the relationship between chronic obstructive pulmonary disease (COPD) assessment test (CAT) and improvements after pulmonary rehabilitation (PR) and PR efficiency in COPD patients.

Comorbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation.
Chronic obstructive pulmonary disease (COPD) is characterized by concomitant systemic manifestations and comorbidities such as cardiovascular disease. Little data exist on the prevalence of comorbidities and medication burden in people with COPD atte

Early chronic obstructive pulmonary disease: definition, assessment, and prevention.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. COPD, however, is a heterogeneous collection of diseases with differing causes, pathogenic mechanisms, and physiological effects. Therefore a comprehensive ap

Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review.
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Comorbidities are often reported in patients with COPD and may influence the cost of care. Yet, the extent by which comorbidities affect costs remai

Treatment of chronic obstructive pulmonary disease in hospitalized geriatric patients.
Chronic obstructive pulmonary disease (COPD) is frequent in older subjects due to deterioration of pulmonary function and lifelong exposure to risk factors. Furthermore, COPD is often underreported because of the gradual onset of symptoms and reduced